Founder and Partner, Dowd Scheffel PLLC
Matthew Dowd focuses his skills on complex appellate and trial litigation, with an emphasis on patent and intellectual property issues. Through his years of practice, Mr. Dowd has successfully worked on numerous high-stakes and eclectic legal matters, focusing primarily on all stages of complex patent matters (AIA proceedings, litigation, prosecution, and counseling). Mr. Dowd's expertise and leadership are regularly consulted, as he is frequently asked to comment in the press on leading intellectual property issues.
Mr. Dowd has substantial experience with Hatch-Waxman litigation, including all stages of opinion analysis, litigation, and appeals. His technical background in medicinal chemistry is ideally suited for litigating pharmaceutical patents. He has represented clients in a range of trial forums for patent disputes, such as the Eastern District of Texas and the District of Delaware, as well as the Patent Trial and Appeal Board at the USPTO.
He has argued and briefed numerous appeals before the U.S. Court of Appeals for the Federal Circuit and other courts involving issues such as patent law, Hatch-Waxman, administrative law, Fifth Amendment takings, contract claims, government employment issues, and criminal law. In 2018, Mr. Dowd is co-counsel with the Hon. Richard Posner (ret.) of U.S. Court of Appeals for the Seventh Circuit in an appeal before the U.S. Court of Appeals for the Fourth Circuit.
In 2013, Mr. Dowd represented Nobel Laureate James Watson, co-discoverer of the DNA double helix, as amicus curiae in the groundbreaking 2013 Supreme Court gene patent case. Mr. Dowd has over 15 years of experience representing clients before the U.S. Patent and Trademark Office.
Mr. Dowd is also well-known for his successful pro bono representation in the "free-range kids" case. The case was widely reported in the national, local, and international news.
Mr. Dowd attended The George Washington University Law School, graduating with high honors and being awarded Order of the Coif. While attending law school and before, Mr. Dowd worked full-time as a registered patent agent at the renowned IP boutique Sterne, Kessler, Goldstein & Fox.
After law school, Mr. Dowd clerked for the Honorable Paul R. Michel, Chief Judge (ret.) of the U.S. Court of Appeals for the Federal Circuit. While a law clerk, Mr. Dowd gained an insider's perspective on the appellate process. Understanding the appellate process is critical to maximizing success at the earlier stages of a case.
Mr. Dowd is currently appointed as a Professorial Lecturer in Law at The George Washington University Law School. He teaches appellate advocacy and is the coach for the student moot court team for the AIPLA Giles Sutherland Rich Moot Court Competition.
Prior to his legal career, Mr. Dowd spent four years in a Ph.D. program in medical chemistry, studying organic chemistry, pharmacology, and pharmaceutical drug design. During his Ph.D. program, Mr. Dowd's research discovered a novel structure-activity relationship for nicotinic ligands with potential utility in treating Alzheimer's and Parkinson's diseases. Mr. Dowd attended The College of William and Mary, in Williamsburg, VA, and Regis High School in New York City.
Principal, Knowles Intellectual Property Strategies
Sherry M. Knowles is an intellectual property attorney with 30 years of experience in global corporate and private practice, and is a member of the inaugural class of the IPWatchdog Masters™ Hall of Fame.
Currently the Principal of Knowles Intellectual Property Strategies, Ms. Knowles was the Senior Vice President and Chief Patent Counsel at GlaxoSmithKline from 2006-2010, where she served as the worldwide head of patents for all litigation and transactional matters, and managed a global department of over 200 people in 12 offices. At GSK, Ms. Knowles was a member of the Scientific Advisory Board, the Technology Investment Board, the Product Management Board, the Legal Management Team and she led the Global Patents Executive Team.
Ms. Knowles played a key role in the case of GlaxoSmithKline and Tafas v. Dudas, 541 F. Supp. 2d 805 (E.D. Va. 2008). On October 9, 2007, GSK became the first and only company in the US to file a lawsuit to challenge the Final Rules published by the US Patent and Trademark Office on August 7, 2007. During the course of litigation, 20 amicus briefs were filed by parties in support of GSK and Dr. Tafas, including from the AIPLA, PhRMA, BIO, IPO, Washington Legal Foundation and CropLife America. The litigation concluded in October 2009, when David Kappos made the decision to withdraw the contested regulations and GSK agreed to join with the PTO in a motion to dismiss all litigation.
In 2008, Managing IP Magazine named Ms. Knowles one of the top 10 most influential people in Intellectual Property, referring to her as a “Patent Owner’s Advocate.” In 2010, the New Jersey Intellectual Property Lawyers Association awarded GSK, with Ms. Knowles as the representative, the Jefferson Medal for exceptional contribution to Intellectual Property. In 2010, Managing IP Magazine named the GSK Global Patent Team the “In-House IP Team of the Year” for 2009 for the constructive approach to IP in the developing world, the engagement with public policy in Europe and the successful resolution of the USPTO rules matter in the US.
In November 2011, Intellectual Asset Management Magazine listed Ms. Knowles among the top fifty key individuals, companies and institutions that have shaped the IP marketplace in the last eight years. Ms. Knowles is also listed in the IAM 250 “World’s Leading IP Strategists,” published by IAM Magazine in 2011, the IAM 300 “World’s Leading IP Strategists,” published by IAM Magazine in 2012, 2013, 2014, 2015, 2016 and 2017 as well as the IAM 1000 “World’s Leading Patent Professionals” in 2015, 2016 and 2017. She was also included in the list of Top 250 Women in IP by Managing IP Magazine in 2014, Managing IP’s 2016 and 2017 list of “IP Stars”.
Ms. Knowles was Chair of the IP Subcommittee of PhRMA in 2008, and Chair Emeritus of the PhRMA IP Subcommittees in 2009 and 2010. From 2006-2010, she was a member of InterPat, which is the association of Chief Patent Counsels of the major pharmaceutical companies, and from 2008-2010 was a member of the Executive Committee of InterPat. She was the Chair of the work stream on data exclusivity for InterPat from 2006-2010.
President & CEO, IPWatchdog, Inc.
Gene Quinn is a patent attorney and a leading commentator on patent law and innovation policy. Mr. Quinn has twice been named one of the top 50 most influential people in IP by Managing IP Magazine, in both 2014 and 2019. From 2017-2023, Mr. Quinn has also been recognized by IAM Magazine as one of the top 300 IP strategists in the world, and in 2021 he was recognized by IAM in their inaugural Strategy 300 Global Leaders list.
Mr. Quinn founded IPWatchdog.com in 1999, and he is currently President & CEO of IPWatchdog, Inc. According to IAM Magazine, Mr. Quinn “has reshaped the IP debate in the United States in a way that has forced policy makers to carefully consider the macroeconomic effects of IP law and its potential to drive innovation and economic activity.”
Regarded as an expert on software patentability and U.S. patent procedure, Mr. Quinn has advised inventors, entrepreneurs and start-up businesses throughout the U.S. and around the world. He consults with attorneys facing peculiar procedural issues at the Patent Office, advises investors and executives on patent law changes and pending litigation matters, and has represented patent practitioners before the Office of Enrollment & Discipline.
Mr. Quinn began his career as a litigator handling a variety of civil litigation matters, and he has been a patent attorney for nearly two decades. He has previously taught a variety of intellectual property courses at the law school level, teaching courses such as patent law, patent claim drafting, patent prosecution, copyright law, trademark law and introduction to intellectual property at Syracuse University College of Law, Temple University School of Law, The University of Toledo College of Law, the University of New Hampshire School of Law, the John Marshall Law School (Chicago) and Whittier Law School. Since 2000 Mr. Quinn has also taught the leading patent bar review course in the nation.
Mr. Quinn is admitted to practice law in New Hampshire, is a Registered Patent Attorney licensed to practice before the United States Patent Office and is also admitted to practice before the United States Court of Appeals for the Federal Circuit.
Managing Attorney, Rogitz & Associates
John M. Rogitz is a second-generation patent attorney that currently serves as Managing Attorney at Rogitz & Associates. He is also a member of the IPWatchdog Advisory Committee and an adjunct professor at Trinity Law School. In addition, John recently served on the Executive Committee of the IP Section of the California Lawyers Association (2023-2025) and co-founded CLA’s AI Interest Group.
As Managing Attorney at Rogitz & Associates, John manages the firm’s day-to-day operations and many of the firm’s clients. He is a registered patent attorney specializing in patent preparation and prosecution in a range of technologies including artificial intelligence, robotics, autonomous vehicles, extended reality, video games, Internet of things (IoT), blockchain, fintech, rules-based software, computer hardware, medical devices, and other electrical and mechanical inventions. His clients range from startups and independent inventors to Fortune 500 companies. Before joining Rogitz & Associates, John was engaged in civil litigation at the Watkins Firm, a San Diego-based law firm.
John teaches all types of IP at Trinity Law School and has also taught IP at the undergraduate level. He writes for IPWatchdog, America’s leading patent law publication, and has also been published by IP Today, IP Magazine, and others. John regularly speaks to trade groups like the National Association of Patent Practitioners and Licensing Executives Society. Prior to practicing law, John worked in industry as a web developer.
John received his J.D. in 2009 from California Western School of Law, where he was selected for the Dean’s List and served as President of the Student Intellectual Property Law Association. John studied physics at Loyola Marymount University where, among other activities, he wrote for the school newspaper and participated in various philanthropic endeavors.
Professor of Law, DePaul University College of Law
Joshua D. Sarnoff is a professor of law at DePaul University and a faculty member in and former director of the Center for Intellectual Property Law & Information Technology (CIPLIT®). He teaches patent law, advanced patent law, administrative law, law and climate change, and other intellectual property law courses. He was previously a professor at the Washington College of Law, American University, in the Glushko-Samuelson Intellectual Property Law Clinic, and at the University of Arizona College of Law. In academic year 2014-2015, Professor Sarnoff was a Thomas A. Edison Distinguished Scholar at the United States Patent and Trademark Office. He is a registered patent attorney and a member of the bars of Washington D.C. and California, a former member of the board of governors of the Federal Circuit Bar Association, and a member of the boards of directors and advisory boards of various nonprofit organizations. He has written numerous articles and book chapters on patent law and climate change and has been involved in a wide range of intellectual property legal and policy disputes. He has submitted testimony on domestic patent law reform bills, has filed numerous amicus briefs in the United States Supreme Court and in the U.S. Court of Appeals for the Federal Circuit on important patent law issues, has been a pro bono mediator for the Federal Circuit, and has been a consultant to the United Nations Conference on Trade and Development on international intellectual property, trade and environmental issues. Professor Sarnoff was formerly in the private practice of intellectual property, environmental, and food and drug law in Washington, D.C. He received his BS from MIT and JD from Stanford.
Founder and Partner, Dowd Scheffel PLLC
Matthew Dowd focuses his skills on complex appellate and trial litigation, with an emphasis on patent and intellectual property issues. Through his years of practice, Mr. Dowd has successfully worked on numerous high-stakes and eclectic legal matters, focusing primarily on all stages of complex patent matters (AIA proceedings, litigation, prosecution, and counseling). Mr. Dowd's expertise and leadership are regularly consulted, as he is frequently asked to comment in the press on leading intellectual property issues.
Mr. Dowd has substantial experience with Hatch-Waxman litigation, including all stages of opinion analysis, litigation, and appeals. His technical background in medicinal chemistry is ideally suited for litigating pharmaceutical patents. He has represented clients in a range of trial forums for patent disputes, such as the Eastern District of Texas and the District of Delaware, as well as the Patent Trial and Appeal Board at the USPTO.
He has argued and briefed numerous appeals before the U.S. Court of Appeals for the Federal Circuit and other courts involving issues such as patent law, Hatch-Waxman, administrative law, Fifth Amendment takings, contract claims, government employment issues, and criminal law. In 2018, Mr. Dowd is co-counsel with the Hon. Richard Posner (ret.) of U.S. Court of Appeals for the Seventh Circuit in an appeal before the U.S. Court of Appeals for the Fourth Circuit.
In 2013, Mr. Dowd represented Nobel Laureate James Watson, co-discoverer of the DNA double helix, as amicus curiae in the groundbreaking 2013 Supreme Court gene patent case. Mr. Dowd has over 15 years of experience representing clients before the U.S. Patent and Trademark Office.
Mr. Dowd is also well-known for his successful pro bono representation in the "free-range kids" case. The case was widely reported in the national, local, and international news.
Mr. Dowd attended The George Washington University Law School, graduating with high honors and being awarded Order of the Coif. While attending law school and before, Mr. Dowd worked full-time as a registered patent agent at the renowned IP boutique Sterne, Kessler, Goldstein & Fox.
After law school, Mr. Dowd clerked for the Honorable Paul R. Michel, Chief Judge (ret.) of the U.S. Court of Appeals for the Federal Circuit. While a law clerk, Mr. Dowd gained an insider's perspective on the appellate process. Understanding the appellate process is critical to maximizing success at the earlier stages of a case.
Mr. Dowd is currently appointed as a Professorial Lecturer in Law at The George Washington University Law School. He teaches appellate advocacy and is the coach for the student moot court team for the AIPLA Giles Sutherland Rich Moot Court Competition.
Prior to his legal career, Mr. Dowd spent four years in a Ph.D. program in medical chemistry, studying organic chemistry, pharmacology, and pharmaceutical drug design. During his Ph.D. program, Mr. Dowd's research discovered a novel structure-activity relationship for nicotinic ligands with potential utility in treating Alzheimer's and Parkinson's diseases. Mr. Dowd attended The College of William and Mary, in Williamsburg, VA, and Regis High School in New York City.
Principal, Knowles Intellectual Property Strategies
Sherry M. Knowles is an intellectual property attorney with 30 years of experience in global corporate and private practice, and is a member of the inaugural class of the IPWatchdog Masters™ Hall of Fame.
Currently the Principal of Knowles Intellectual Property Strategies, Ms. Knowles was the Senior Vice President and Chief Patent Counsel at GlaxoSmithKline from 2006-2010, where she served as the worldwide head of patents for all litigation and transactional matters, and managed a global department of over 200 people in 12 offices. At GSK, Ms. Knowles was a member of the Scientific Advisory Board, the Technology Investment Board, the Product Management Board, the Legal Management Team and she led the Global Patents Executive Team.
Ms. Knowles played a key role in the case of GlaxoSmithKline and Tafas v. Dudas, 541 F. Supp. 2d 805 (E.D. Va. 2008). On October 9, 2007, GSK became the first and only company in the US to file a lawsuit to challenge the Final Rules published by the US Patent and Trademark Office on August 7, 2007. During the course of litigation, 20 amicus briefs were filed by parties in support of GSK and Dr. Tafas, including from the AIPLA, PhRMA, BIO, IPO, Washington Legal Foundation and CropLife America. The litigation concluded in October 2009, when David Kappos made the decision to withdraw the contested regulations and GSK agreed to join with the PTO in a motion to dismiss all litigation.
In 2008, Managing IP Magazine named Ms. Knowles one of the top 10 most influential people in Intellectual Property, referring to her as a “Patent Owner’s Advocate.” In 2010, the New Jersey Intellectual Property Lawyers Association awarded GSK, with Ms. Knowles as the representative, the Jefferson Medal for exceptional contribution to Intellectual Property. In 2010, Managing IP Magazine named the GSK Global Patent Team the “In-House IP Team of the Year” for 2009 for the constructive approach to IP in the developing world, the engagement with public policy in Europe and the successful resolution of the USPTO rules matter in the US.
In November 2011, Intellectual Asset Management Magazine listed Ms. Knowles among the top fifty key individuals, companies and institutions that have shaped the IP marketplace in the last eight years. Ms. Knowles is also listed in the IAM 250 “World’s Leading IP Strategists,” published by IAM Magazine in 2011, the IAM 300 “World’s Leading IP Strategists,” published by IAM Magazine in 2012, 2013, 2014, 2015, 2016 and 2017 as well as the IAM 1000 “World’s Leading Patent Professionals” in 2015, 2016 and 2017. She was also included in the list of Top 250 Women in IP by Managing IP Magazine in 2014, Managing IP’s 2016 and 2017 list of “IP Stars”.
Ms. Knowles was Chair of the IP Subcommittee of PhRMA in 2008, and Chair Emeritus of the PhRMA IP Subcommittees in 2009 and 2010. From 2006-2010, she was a member of InterPat, which is the association of Chief Patent Counsels of the major pharmaceutical companies, and from 2008-2010 was a member of the Executive Committee of InterPat. She was the Chair of the work stream on data exclusivity for InterPat from 2006-2010.
President & CEO, IPWatchdog, Inc.
Gene Quinn is a patent attorney and a leading commentator on patent law and innovation policy. Mr. Quinn has twice been named one of the top 50 most influential people in IP by Managing IP Magazine, in both 2014 and 2019. From 2017-2023, Mr. Quinn has also been recognized by IAM Magazine as one of the top 300 IP strategists in the world, and in 2021 he was recognized by IAM in their inaugural Strategy 300 Global Leaders list.
Mr. Quinn founded IPWatchdog.com in 1999, and he is currently President & CEO of IPWatchdog, Inc. According to IAM Magazine, Mr. Quinn “has reshaped the IP debate in the United States in a way that has forced policy makers to carefully consider the macroeconomic effects of IP law and its potential to drive innovation and economic activity.”
Regarded as an expert on software patentability and U.S. patent procedure, Mr. Quinn has advised inventors, entrepreneurs and start-up businesses throughout the U.S. and around the world. He consults with attorneys facing peculiar procedural issues at the Patent Office, advises investors and executives on patent law changes and pending litigation matters, and has represented patent practitioners before the Office of Enrollment & Discipline.
Mr. Quinn began his career as a litigator handling a variety of civil litigation matters, and he has been a patent attorney for nearly two decades. He has previously taught a variety of intellectual property courses at the law school level, teaching courses such as patent law, patent claim drafting, patent prosecution, copyright law, trademark law and introduction to intellectual property at Syracuse University College of Law, Temple University School of Law, The University of Toledo College of Law, the University of New Hampshire School of Law, the John Marshall Law School (Chicago) and Whittier Law School. Since 2000 Mr. Quinn has also taught the leading patent bar review course in the nation.
Mr. Quinn is admitted to practice law in New Hampshire, is a Registered Patent Attorney licensed to practice before the United States Patent Office and is also admitted to practice before the United States Court of Appeals for the Federal Circuit.
Managing Attorney, Rogitz & Associates
John M. Rogitz is a second-generation patent attorney that currently serves as Managing Attorney at Rogitz & Associates. He is also a member of the IPWatchdog Advisory Committee and an adjunct professor at Trinity Law School. In addition, John recently served on the Executive Committee of the IP Section of the California Lawyers Association (2023-2025) and co-founded CLA’s AI Interest Group.
As Managing Attorney at Rogitz & Associates, John manages the firm’s day-to-day operations and many of the firm’s clients. He is a registered patent attorney specializing in patent preparation and prosecution in a range of technologies including artificial intelligence, robotics, autonomous vehicles, extended reality, video games, Internet of things (IoT), blockchain, fintech, rules-based software, computer hardware, medical devices, and other electrical and mechanical inventions. His clients range from startups and independent inventors to Fortune 500 companies. Before joining Rogitz & Associates, John was engaged in civil litigation at the Watkins Firm, a San Diego-based law firm.
John teaches all types of IP at Trinity Law School and has also taught IP at the undergraduate level. He writes for IPWatchdog, America’s leading patent law publication, and has also been published by IP Today, IP Magazine, and others. John regularly speaks to trade groups like the National Association of Patent Practitioners and Licensing Executives Society. Prior to practicing law, John worked in industry as a web developer.
John received his J.D. in 2009 from California Western School of Law, where he was selected for the Dean’s List and served as President of the Student Intellectual Property Law Association. John studied physics at Loyola Marymount University where, among other activities, he wrote for the school newspaper and participated in various philanthropic endeavors.
Professor of Law, DePaul University College of Law
Joshua D. Sarnoff is a professor of law at DePaul University and a faculty member in and former director of the Center for Intellectual Property Law & Information Technology (CIPLIT®). He teaches patent law, advanced patent law, administrative law, law and climate change, and other intellectual property law courses. He was previously a professor at the Washington College of Law, American University, in the Glushko-Samuelson Intellectual Property Law Clinic, and at the University of Arizona College of Law. In academic year 2014-2015, Professor Sarnoff was a Thomas A. Edison Distinguished Scholar at the United States Patent and Trademark Office. He is a registered patent attorney and a member of the bars of Washington D.C. and California, a former member of the board of governors of the Federal Circuit Bar Association, and a member of the boards of directors and advisory boards of various nonprofit organizations. He has written numerous articles and book chapters on patent law and climate change and has been involved in a wide range of intellectual property legal and policy disputes. He has submitted testimony on domestic patent law reform bills, has filed numerous amicus briefs in the United States Supreme Court and in the U.S. Court of Appeals for the Federal Circuit on important patent law issues, has been a pro bono mediator for the Federal Circuit, and has been a consultant to the United Nations Conference on Trade and Development on international intellectual property, trade and environmental issues. Professor Sarnoff was formerly in the private practice of intellectual property, environmental, and food and drug law in Washington, D.C. He received his BS from MIT and JD from Stanford.
Founder and Partner, Dowd Scheffel PLLC
Matthew Dowd focuses his skills on complex appellate and trial litigation, with an emphasis on patent and intellectual property issues. Through his years of practice, Mr. Dowd has successfully worked on numerous high-stakes and eclectic legal matters, focusing primarily on all stages of complex patent matters (AIA proceedings, litigation, prosecution, and counseling). Mr. Dowd's expertise and leadership are regularly consulted, as he is frequently asked to comment in the press on leading intellectual property issues.
Mr. Dowd has substantial experience with Hatch-Waxman litigation, including all stages of opinion analysis, litigation, and appeals. His technical background in medicinal chemistry is ideally suited for litigating pharmaceutical patents. He has represented clients in a range of trial forums for patent disputes, such as the Eastern District of Texas and the District of Delaware, as well as the Patent Trial and Appeal Board at the USPTO.
He has argued and briefed numerous appeals before the U.S. Court of Appeals for the Federal Circuit and other courts involving issues such as patent law, Hatch-Waxman, administrative law, Fifth Amendment takings, contract claims, government employment issues, and criminal law. In 2018, Mr. Dowd is co-counsel with the Hon. Richard Posner (ret.) of U.S. Court of Appeals for the Seventh Circuit in an appeal before the U.S. Court of Appeals for the Fourth Circuit.
In 2013, Mr. Dowd represented Nobel Laureate James Watson, co-discoverer of the DNA double helix, as amicus curiae in the groundbreaking 2013 Supreme Court gene patent case. Mr. Dowd has over 15 years of experience representing clients before the U.S. Patent and Trademark Office.
Mr. Dowd is also well-known for his successful pro bono representation in the "free-range kids" case. The case was widely reported in the national, local, and international news.
Mr. Dowd attended The George Washington University Law School, graduating with high honors and being awarded Order of the Coif. While attending law school and before, Mr. Dowd worked full-time as a registered patent agent at the renowned IP boutique Sterne, Kessler, Goldstein & Fox.
After law school, Mr. Dowd clerked for the Honorable Paul R. Michel, Chief Judge (ret.) of the U.S. Court of Appeals for the Federal Circuit. While a law clerk, Mr. Dowd gained an insider's perspective on the appellate process. Understanding the appellate process is critical to maximizing success at the earlier stages of a case.
Mr. Dowd is currently appointed as a Professorial Lecturer in Law at The George Washington University Law School. He teaches appellate advocacy and is the coach for the student moot court team for the AIPLA Giles Sutherland Rich Moot Court Competition.
Prior to his legal career, Mr. Dowd spent four years in a Ph.D. program in medical chemistry, studying organic chemistry, pharmacology, and pharmaceutical drug design. During his Ph.D. program, Mr. Dowd's research discovered a novel structure-activity relationship for nicotinic ligands with potential utility in treating Alzheimer's and Parkinson's diseases. Mr. Dowd attended The College of William and Mary, in Williamsburg, VA, and Regis High School in New York City.
Professor of Law, St. Mary's University Law School
Adam MacLeod is a Professor at St. Mary's University School of Law. He has been a visiting fellow in the James Madison Program in American Ideals and Institutions at Princeton University, a fellow of the Center for Religion, Culture and Democracy, and a Senior Scholar and Thomas Edison Fellow in the Center for Intellectual Property x Innovation Policy at George Mason University. He is co-editor of Christie & Martin's Jurisprudence (4th ed. West 2020) and author of Property and Practical Reason (Cambridge University Press 2015). He has written two other books, dozens of scholarly articles, and more than one hundred essays and book reviews.
Professor MacLeod received his B.A., summa cum laude, from Gordon College and his J.D., magna cum laude, from the University of Notre Dame Law School. After law school, he served as law clerk to Chief Justice Christopher Armstrong and Justice Benjamin Kaplan of the Massachusetts Appeals Court and to Chief Judge Lewis Babcock of the United States District Court for the District of Colorado. He practiced law in the Boston area and has held appointment as a special Deputy Attorney General of Alabama and a lecturer in the Alabama Judicial College. He also serves as an Operational Auxiliarist in the U.S. Coast Guard, advising and providing operational training to Auxiliary and active-duty personnel.
Founder and Partner, Dowd Scheffel PLLC
Matthew Dowd focuses his skills on complex appellate and trial litigation, with an emphasis on patent and intellectual property issues. Through his years of practice, Mr. Dowd has successfully worked on numerous high-stakes and eclectic legal matters, focusing primarily on all stages of complex patent matters (AIA proceedings, litigation, prosecution, and counseling). Mr. Dowd's expertise and leadership are regularly consulted, as he is frequently asked to comment in the press on leading intellectual property issues.
Mr. Dowd has substantial experience with Hatch-Waxman litigation, including all stages of opinion analysis, litigation, and appeals. His technical background in medicinal chemistry is ideally suited for litigating pharmaceutical patents. He has represented clients in a range of trial forums for patent disputes, such as the Eastern District of Texas and the District of Delaware, as well as the Patent Trial and Appeal Board at the USPTO.
He has argued and briefed numerous appeals before the U.S. Court of Appeals for the Federal Circuit and other courts involving issues such as patent law, Hatch-Waxman, administrative law, Fifth Amendment takings, contract claims, government employment issues, and criminal law. In 2018, Mr. Dowd is co-counsel with the Hon. Richard Posner (ret.) of U.S. Court of Appeals for the Seventh Circuit in an appeal before the U.S. Court of Appeals for the Fourth Circuit.
In 2013, Mr. Dowd represented Nobel Laureate James Watson, co-discoverer of the DNA double helix, as amicus curiae in the groundbreaking 2013 Supreme Court gene patent case. Mr. Dowd has over 15 years of experience representing clients before the U.S. Patent and Trademark Office.
Mr. Dowd is also well-known for his successful pro bono representation in the "free-range kids" case. The case was widely reported in the national, local, and international news.
Mr. Dowd attended The George Washington University Law School, graduating with high honors and being awarded Order of the Coif. While attending law school and before, Mr. Dowd worked full-time as a registered patent agent at the renowned IP boutique Sterne, Kessler, Goldstein & Fox.
After law school, Mr. Dowd clerked for the Honorable Paul R. Michel, Chief Judge (ret.) of the U.S. Court of Appeals for the Federal Circuit. While a law clerk, Mr. Dowd gained an insider's perspective on the appellate process. Understanding the appellate process is critical to maximizing success at the earlier stages of a case.
Mr. Dowd is currently appointed as a Professorial Lecturer in Law at The George Washington University Law School. He teaches appellate advocacy and is the coach for the student moot court team for the AIPLA Giles Sutherland Rich Moot Court Competition.
Prior to his legal career, Mr. Dowd spent four years in a Ph.D. program in medical chemistry, studying organic chemistry, pharmacology, and pharmaceutical drug design. During his Ph.D. program, Mr. Dowd's research discovered a novel structure-activity relationship for nicotinic ligands with potential utility in treating Alzheimer's and Parkinson's diseases. Mr. Dowd attended The College of William and Mary, in Williamsburg, VA, and Regis High School in New York City.
Partner, Duane Morris LLP
Brian Pandya is Partner at Duane Morris LLP. A member of the firm’s Trial Practice Group, Brian represents technology, manufacturing, and healthcare companies in high-stakes litigation, arbitrations, investigations and appeals. He has served as lead trial counsel in a range of intellectual property, antitrust, complex commercial and white-collar matters. He also regularly counsels clients on cybersecurity and national security issues, particularly matters concerning emerging technologies and artificial intelligence.
Before joining Duane Morris, Brian served at the U.S. Department of Justice as Deputy Associate Attorney General from 2019-21, where he oversaw investigations and litigation undertaken by the Antitrust Division and Civil Division and served on several high-profile task forces and trial teams. Brian was also previously a litigation and IP partner at another prominent Washington, DC firm.
Brian clerked for Judge Leonard Davis on the United States District Court for the Eastern District of Texas. He is a two-time recipient of the Federal Circuit Bar Association’s Pro Bono Advocacy Award for work on behalf of military veterans and has served as volunteer federal public defender in the Eastern District of Virginia, among many other bar and community engagements.
Brian graduated cum laude from the University of Michigan Law School, where he was articles editor of the Michigan Telecommunications and Technology Law Review, and with honors and high distinction in mechanical engineering from Penn State University, where he received the Ralph Dorn Hetzel Memorial Award.
Founder and Partner, Dowd Scheffel PLLC
Matthew Dowd focuses his skills on complex appellate and trial litigation, with an emphasis on patent and intellectual property issues. Through his years of practice, Mr. Dowd has successfully worked on numerous high-stakes and eclectic legal matters, focusing primarily on all stages of complex patent matters (AIA proceedings, litigation, prosecution, and counseling). Mr. Dowd's expertise and leadership are regularly consulted, as he is frequently asked to comment in the press on leading intellectual property issues.
Mr. Dowd has substantial experience with Hatch-Waxman litigation, including all stages of opinion analysis, litigation, and appeals. His technical background in medicinal chemistry is ideally suited for litigating pharmaceutical patents. He has represented clients in a range of trial forums for patent disputes, such as the Eastern District of Texas and the District of Delaware, as well as the Patent Trial and Appeal Board at the USPTO.
He has argued and briefed numerous appeals before the U.S. Court of Appeals for the Federal Circuit and other courts involving issues such as patent law, Hatch-Waxman, administrative law, Fifth Amendment takings, contract claims, government employment issues, and criminal law. In 2018, Mr. Dowd is co-counsel with the Hon. Richard Posner (ret.) of U.S. Court of Appeals for the Seventh Circuit in an appeal before the U.S. Court of Appeals for the Fourth Circuit.
In 2013, Mr. Dowd represented Nobel Laureate James Watson, co-discoverer of the DNA double helix, as amicus curiae in the groundbreaking 2013 Supreme Court gene patent case. Mr. Dowd has over 15 years of experience representing clients before the U.S. Patent and Trademark Office.
Mr. Dowd is also well-known for his successful pro bono representation in the "free-range kids" case. The case was widely reported in the national, local, and international news.
Mr. Dowd attended The George Washington University Law School, graduating with high honors and being awarded Order of the Coif. While attending law school and before, Mr. Dowd worked full-time as a registered patent agent at the renowned IP boutique Sterne, Kessler, Goldstein & Fox.
After law school, Mr. Dowd clerked for the Honorable Paul R. Michel, Chief Judge (ret.) of the U.S. Court of Appeals for the Federal Circuit. While a law clerk, Mr. Dowd gained an insider's perspective on the appellate process. Understanding the appellate process is critical to maximizing success at the earlier stages of a case.
Mr. Dowd is currently appointed as a Professorial Lecturer in Law at The George Washington University Law School. He teaches appellate advocacy and is the coach for the student moot court team for the AIPLA Giles Sutherland Rich Moot Court Competition.
Prior to his legal career, Mr. Dowd spent four years in a Ph.D. program in medical chemistry, studying organic chemistry, pharmacology, and pharmaceutical drug design. During his Ph.D. program, Mr. Dowd's research discovered a novel structure-activity relationship for nicotinic ligands with potential utility in treating Alzheimer's and Parkinson's diseases. Mr. Dowd attended The College of William and Mary, in Williamsburg, VA, and Regis High School in New York City.
Partner, Duane Morris LLP
Brian Pandya is Partner at Duane Morris LLP. A member of the firm’s Trial Practice Group, Brian represents technology, manufacturing, and healthcare companies in high-stakes litigation, arbitrations, investigations and appeals. He has served as lead trial counsel in a range of intellectual property, antitrust, complex commercial and white-collar matters. He also regularly counsels clients on cybersecurity and national security issues, particularly matters concerning emerging technologies and artificial intelligence.
Before joining Duane Morris, Brian served at the U.S. Department of Justice as Deputy Associate Attorney General from 2019-21, where he oversaw investigations and litigation undertaken by the Antitrust Division and Civil Division and served on several high-profile task forces and trial teams. Brian was also previously a litigation and IP partner at another prominent Washington, DC firm.
Brian clerked for Judge Leonard Davis on the United States District Court for the Eastern District of Texas. He is a two-time recipient of the Federal Circuit Bar Association’s Pro Bono Advocacy Award for work on behalf of military veterans and has served as volunteer federal public defender in the Eastern District of Virginia, among many other bar and community engagements.
Brian graduated cum laude from the University of Michigan Law School, where he was articles editor of the Michigan Telecommunications and Technology Law Review, and with honors and high distinction in mechanical engineering from Penn State University, where he received the Ralph Dorn Hetzel Memorial Award.
Textualism and Patent Statutory Law – Patent Eligibility, ODP, and Upcoming Patent Reform in Congress
Matthew J. Dowd, Sherry Knowles, Gene Quinn, John M. Rogitz, Joshua Sarnoff
When it comes to patent eligibility and statutory construction, does “any” really mean “any?” In...
Textualism and Patent Statutory Law – Patent Eligibility, ODP, and Upcoming Patent Reform in Congress
Matthew J. Dowd, Sherry Knowles, Gene Quinn, John M. Rogitz, Joshua Sarnoff
When it comes to patent eligibility and statutory construction, does “any” really mean “any?” In...
Courthouse Steps Decision Teleforum: Return Mail v. US Postal Service
Matthew J. Dowd, Adam MacLeod
In Return Mail v. US Postal Service, the Supreme Court held that the United States...
Courthouse Steps: SAS Institute Inc. v. Iancu Decided
Matthew J. Dowd, Brian Pandya
Intellectual Property Practice Group and Regulatory Transparency Project Teleforum
When Congress directs the Patent Office to resolve “any” patent claims a petitioner challenges, must...
Courthouse Steps: Oil States and SAS Institute Inc. v. Matal
Matthew J. Dowd, Brian Pandya
Intellectual Property Practice Group and Regulatory Transparency Project Teleforum
Oil States Energy Services v. Greene’s Energy Group Has the administrative state gone too far into...